This inventor holds 1 USPTO granted patent. Top assignee: Eureka Therapeutics, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovations of Hong Liu
Introduction
Hong Liu is a notable inventor recognized for his contributions to the field of biotechnology. He is currently associated with Eureka Therapeutics, Inc., where he focuses on developing innovative solutions in medical science. His work has led to significant advancements in understanding and utilizing glypican 3.
Latest Patents
Hong Liu holds a patent titled "Constructs Specifically Recognizing Glypican 3 and Uses Thereof." This patent highlights his innovative approach to targeting glypican 3, which has implications for various therapeutic applications. He has 1 patent to his name, showcasing his commitment to advancing medical research.
Career Highlights
Throughout his career, Hong Liu has made substantial contributions to the field of biotechnology. His work at Eureka Therapeutics, Inc. has positioned him as a key player in the development of novel therapeutic strategies. His expertise and innovative mindset have been instrumental in driving research forward.
Collaborations
Hong Liu collaborates with talented individuals such as Jingyi Xiang and Yiyang Xu. Together, they work on projects that aim to enhance the understanding of glypican 3 and its potential applications in medicine.
Conclusion
In summary, Hong Liu is a distinguished inventor whose work has significantly impacted the field of biotechnology. His patent on glypican 3 demonstrates his innovative spirit and dedication to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile